Ethics and Oncology: New Issues of Therapy, Care, and Research

Monika Bobbert; Beate Herrmann; Wolfgang U. Eckart

doi:10.5771/9783495813430

Summary

The advances in oncological therapy as well as the knowledge of the limitations to what is possible pose major ethical challenges for doctors, nurses and patients: The possibilities for treatment in oncology are expanding continuously. As a result patients are involved with increasingly complex treatment decisions, including end of life decisions. As a consequence doctors must inform their patients adequately, deliver difficult news and advise patients and their relatives on treatment goals and changes thereto, e.g. when changing from curative to palliative care.

This interdisciplinary conference with experts from a wide range of fields provides an opportunity to initiate and deepen the discussion of the above-mentioned issues.

Keywords

Search publication

Bibliographic data

Copyright Year: 2018
ISBN-Print: 978-3-495-48586-6
ISBN-Online: 978-3-495-81343-0
Publisher: Karl Alber, Baden-Baden
Series: Angewandte Ethik
Volume: 19
Language: English
Pages: 176
Product Type: Edited Book

Titelei/Inhaltsverzeichnis No access Pages 1 - 6
1. Interdisciplinary and contextual ethical perspective No access
2. New Issues of Therapy, Care, and Research No access
3. Caring for Cancer Patients No access
4. Ethics and end-of-life decision making No access
5. opportunities, risks, and perspectives No access
1. Authors:
  1. 1 Introduction No access
    Authors:
  2. 2 Basic principles of communication in the clinical setting No access
    Authors:
  3. 3 Communication in oncology: education and assessment No access
    Authors:
  4. Authors:
    1. 4.1 Evolution of truth telling attitudes and practices No access
      Authors:
    2. 4.2 Communication in palliative and end of life care No access
      Authors:
    3. 4.3 Communication with families No access
      Authors:
    4. 4.4 Cross-cultural communication with cancer patients No access
      Authors:
  5. 5 Conclusion No access
    Authors:
  6. References No access
    Authors:
2. Authors:
  1. 1 Introduction No access
    Authors:
  2. 2 Fields of action of the oncology nurse No access
    Authors:
  3. Authors:
    1. 3.1 Professional care according to »state of the art« No access
      Authors:
    2. 3.2 Relationship between patient and nurse and the nurse’s attitudes No access
      Authors:
    3. 3.3 Symptom management and quality of life No access
      Authors:
    4. 3.4 End-of-life care No access
      Authors:
    5. 3.5 Distribution of resources and justice No access
      Authors:
    6. 3.6 Cultural differences, beliefs and needs No access
      Authors:
  4. Authors:
    1. 4.1 Patient information and education No access
      Authors:
    2. 4.2 Different views in regard to medical treatment No access
      Authors:
    3. 4.3 Nurses role of patients advocate and translator No access
      Authors:
  5. 5 The family No access
    Authors:
  6. 6 The institution No access
    Authors:
  7. 7 Research in Nursing and Medicine No access
    Authors:
  8. 8 Summary No access
    Authors:
  9. References No access
    Authors:
3. Authors:
  1. Introduction No access
    Authors:
  2. Options of fertility preservation in cancer patients No access
    Authors:
  3. Fertiprotekt: A network on fertility preservation in German speaking countries No access
    Authors:
  4. Counseling on fertility preservation No access
    Authors:
  5. General ethical considerations No access
    Authors:
  6. Discussion of autonomy and presentation of an alternative ethical concept No access
    Authors:
  7. Conclusion No access
    Authors:
  8. References No access
    Authors:
4. Authors:
  1. 1 Introduction No access
    Authors:
  2. 2 Children No access
    Authors:
  3. 3 Vulnerability No access
    Authors:
  4. 4 Children’s Rights No access
    Authors:
  5. 5 The four-sided interplay No access
    Authors:
  6. 6 The case of Nemo No access
    Authors:
  7. 7 Conclusion No access
    Authors:
  8. References No access
    Authors:
5. Authors:
  1. Introduction No access
    Authors:
  2. The construct of a child’s duty to donate No access
    Authors:
  3. Parents’ duties No access
    Authors:
  4. The child’s duty? No access
    Authors:
  5. Authors:
    1. (I) Action done from duty vs. action done from inclination No access
      Authors:
    2. (II) Perfect vs. imperfect duties No access
      Authors:
    3. (III) Actions done according to duty vs. actions done from duty No access
      Authors:
  6. First strategy: Parents transfer their duty to the child No access
    Authors:
  7. Second strategy: The best interest of the child implies his or her duty No access
    Authors:
  8. Third strategy: Siblings have duties toward each other because of their intimate family relationships No access
    Authors:
  9. Conclusion: Difficulties of the assumption of a duty of a child to donate No access
    Authors:
  10. References No access
    Authors:
1. Authors:
  1. 1 Klara and Kurt No access
    Authors:
  2. 2 A model of what it can mean to wish to die No access
    Authors:
  3. 3 Ethical implications of wish to die statements No access
    Authors:
2. Authors:
  1. 1 Introduction No access
    Authors:
  2. Authors:
    1. 2.1 Diagnosis and prognosis No access
      Authors:
    2. 2.2 Medical indication No access
      Authors:
    3. 2.3 Therapeutic »futility« No access
      Authors:
  3. Authors:
    1. 3.1 The prima facie goal: Saving life No access
      Authors:
    2. 3.2 Responsible dealing with prognostic uncertainty No access
      Authors:
    3. 3.3 Weighing potential burdens and damage, relief and benefit No access
      Authors:
    4. 3.4 Resistence against ideas of quality of life No access
      Authors:
    5. 3.5 Narrow frame for the concept of alleged will No access
      Authors:
    6. 3.6 Attention to the »paradox of handicap« as empirical phenomenon No access
      Authors:
  4. Authors:
    1. 4.1 The right of self-determination in questions of therapy No access
      Authors:
    2. 4.2 The norm of non-damage No access
      Authors:
  5. 5 Conclusion: The value of ethical norms and rules No access
    Authors:
  6. References No access
    Authors:
3. Authors:
  1. 1 Introduction No access
    Authors:
  2. 2 Medical indication, aim of treatment and will of the patient No access
    Authors:
  3. 3 The German law for advance directives of 2009: The normative perspective No access
    Authors:
  4. Authors:
    1. Who should take the initiative for setting up an advance directive? No access
      Authors:
    2. Bindingness of advance directives No access
      Authors:
  5. Authors:
    1. Combination of advance directive and health care proxy No access
      Authors:
  6. References No access
    Authors:
1. Authors:
  1. 1 Introduction No access
    Authors:
  2. 2 Aims and interests of medical research No access
    Authors:
  3. 3 Ethics committees in medical research No access
    Authors:
  4. Authors:
    1. Choice and definition of outcome variables No access
      Authors:
    2. Choice of the study design No access
      Authors:
    3. Choice of the statistical analysis strategy No access
      Authors:
    4. Calculation of sample size No access
      Authors:
  5. 5 Conclusion No access
    Authors:
  6. References No access
    Authors:
2. Authors:
  1. 1 Population database and unexpected findings No access
    Authors:
  2. 2 Iceland’s population database research No access
    Authors:
  3. 3 Return of results to individuals? No access
    Authors:
  4. Authors:
    1. 4.1 Do nothing No access
      Authors:
    2. 4.2 Giving option of knowing No access
      Authors:
    3. 4.3 Make availability of information publicly known No access
      Authors:
  5. Authors:
    1. 5.1 Restricted informed consent No access
      Authors:
    2. 5.2 General open consent No access
      Authors:
    3. 5.3 Authorization and dynamic consent No access
      Authors:
    4. 5.4 Authorization for return: two forms No access
      Authors:
  6. 6 Conclusion No access
    Authors:
  7. References No access
    Authors:
3. New ›elixirs‹&ga;: The Problem of changing therapeutic target with Erbitux and Avastin No access Pages 168 - 173
  Authors:
Authors and Institutions No access Pages 174 - 176